RE:RE:RE:Little sedi action.True. Merck offered Seagen $40b last year and talks fell through, so maybe Merck will reenter the fray to outbid PFE. It's a bit unsettling as Seagen has a lot of cancer stuff, and we don't need all the BP'S fighting over then and ignoring little old Onc. We have to remember that PFE had an exclusive with Onc years ago with a dog cancer therapy and they left Onc holding the bag on that one. They've stuck it to Onc before & could do it again with this latest exclusivity.